Qnostics is part of the BBI Holdings Plc group of companies.
About Us Products & Services Contact
 
Our objective is to support the improvement of analysis and control of human infectious diseases by providing high quality evaluation materials to aid in the advancement of nucleic acid technologies.
Qnostics is focused on the development, manufacture and supply of specialised molecular Quality Control materials for use in clinical and commercial laboratories.

Our primary focus is infectious diseases, and a synergistic partnership with QCMD, a leading International External Quality Assessment (EQA) organization, has enabled Qnostics to develop, support, and satisfy the clinical diagnostic community's need for molecular control materials.

The relationship with QCMD allows Qnostics the potential for scientific 'peer-review' to its products, the quality and 'branding' of the QC materials. Qnostics are also a QCMD approved supplier.

The QC material Qnostics provides is used routinely for the evaluation and investigation of the laboratory and the molecular technologies that they use.